Immunotherapy, or the ability to use a person’s own immune system to fight cancer, is rising as a promising treatment option in cancer care. In our first episode of our Cancer HealthCasts miniseries, we talk to one of the fathers of successful immunotherapy, Dr. Steven Rosenberg, about how a study he’s leading is unveiling a new form of personalized immunotherapy using tumor-infiltrating lymphocytes to combat metastatic breast cancer.
Cancer HealthCast
34m listen
How Personalized Immunotherapy Can Help Combat Metastatic Breast Cancer
Share
A recent NCI study explores new immunotherapy treatment for metastatic breast cancer.
-
Dr. Steven Rosenberg Surgery Branch Chief, Center for Cancer Research NCI
Related Content
-
New NPS Challenge Aims to Rewrite How the Military Builds Missiles
Officials say focusing on design methods, not hardware, could unlock fast, low‑cost manufacturing for future munitions.
11m watch -
The Value of ‘Pause, Breathe, Summarize’ in Cyber Leadership
A simple framework for clarity when everything feels urgent.
25m listen -
NIST Explains What’s Next for Federal AI Standards
NIST’s Martin Stanley outlines how AI control overlays, risk frameworks and future guidance will support agencies scaling AI systems.
6m watch -
CISA CIO on Agentic AI, Building the Cyber Workforce
Bob Costello discusses deploying agentic AI, speeding cyber approvals and strengthening the federal cybersecurity talent pipeline.
9m watch
